Amisulpride: ook in Nederland een behandeloptie voor patiënten met een psychotische stoornis ; Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands
BACKGROUND: The antipsychotic drug amisulpride has not yet been officially approved for use in the Netherlands, although it is already available in other European countries , including Belgium, the UK and Germany. However, a fast-track procedure has recently been initiated so that amisulpride will soon become available in the Netherlands as well. AIM: To summarise the efficacy and side effects of amisulpride. METHOD: We discuss the evidence presented in the scientific literature. RESULTS: The scientific literature assures us that amisulpride is an effective antipsychotic drug with an acceptabl... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2015 |
Schlagwörter: | Antipsychotic Agents / Humans / amisulpride / antipsychotica / schizofrenie / Psychotic Disorders / Sulpiride |
Sprache: | Niederländisch |
Permalink: | https://search.fid-benelux.de/Record/base-29140471 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dspace.library.uu.nl/handle/1874/338439 |
BACKGROUND: The antipsychotic drug amisulpride has not yet been officially approved for use in the Netherlands, although it is already available in other European countries , including Belgium, the UK and Germany. However, a fast-track procedure has recently been initiated so that amisulpride will soon become available in the Netherlands as well. AIM: To summarise the efficacy and side effects of amisulpride. METHOD: We discuss the evidence presented in the scientific literature. RESULTS: The scientific literature assures us that amisulpride is an effective antipsychotic drug with an acceptable range of side-effects. This means that there are two main advantages that ensue from the use of amisulpride: a patient's psychosis is more likely to go into remission and patients are less likely to stop taking the drug. CONCLUSION: The availability of amisulpride in the Netherlands will constitute a valuable addition to the pharmacotherapeutic options for treating psychotic disorders in our county.